Pharmaco-enhancement in Rheumatoid Arthritis with Cobicistat to dose Tofacitinib In Clinic Adequately Low. A within-subject sequential study.
Latest Information Update: 07 Jan 2022
At a glance
- Drugs Cobicistat (Primary) ; Tofacitinib (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms PRACTICAL
- 09 Nov 2021 Results presented at the ACR Convergence 2021
- 12 Aug 2021 New trial record